Dopamine Beta-Hydroxylase (DBH) gene and schizophrenia phenotypic variability: A genetic association study

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 117 B, Issue 1, 2003, Pages 33-38

  Yamamoto, Kenji ^a,b   Cubells, Joseph F ^c   Gelernter, Joel ^c   Benkelfat, Chawki ^d   Lalonde, Pierre ^e   Bloom, David ^a   Lal, Samarthji ^a,f   Labelle, Alain ^g   Turecki, Gustavo ^a,d   Rouleau, Guy A ^f   Joober, Ridha ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^f MONTREAL GENERAL HOSPITAL   (Canada)

^g ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

Dopamine Beta Hydroxylase; Neuroleptic responsiveness; Population stratification; Positive symptom; Schizophrenia

Indexed keywords

CHLORPROMAZINE; COCAINE; DOPAMINE BETA MONOOXYGENASE; NEUROLEPTIC AGENT;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; DOPAMINE BETA HYDROXYLASE GENE; GENE; GENE ACTIVITY; GENE ISOLATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PARANOIA; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

EID: 0042824008     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.10011     Document Type: Article

References (31)

1. Arato M, Bagdy G, Blumel F, Perenyi A, Rihmer Z. 1983. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics. Pharmacopsychiatria 16:19-22.
2. Arrufat FJ, Diaz R, Queralt R, Navarro V, Marcos T, Massana G, Massana J, Ballesta F, Oliva R. 2000. Analysis of the polymorphic (GT)(n) repeat at the dopamine beta-hydroxylase gene in Spanish patients affected by schizophrenia. Am J Med Genet 96:88-92.
3. Birnbaum SG, Podell DM, Arnsten AF. 2000. Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats. Pharmacol Biochem Behav 67:397-403.
4. Cubells JF, Van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH, Malison R, Rao PA, Kobayashi K, Nagatsu T, Gelernter J. 1998. Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 102:533-540.
5. Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J. 2000. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5:56-63.
6. DeLisi LE, Wise CD, Potkin SG, Zalcman S, Phelps BH, Lovenberg W, Wyatt RJ. 1980. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia. Biol Psychiatry 15:895-907.
7. Dunnette J, Weinshilboum R. 1976. Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. Am J Hum Genet 28:155-166.
8. Endicott J, Spitzer RL, Fleiss JL, Cohen J. 1976. The global assessment scale, a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766-771.
9. Friedman JI, Adler DN, Davis KL. 1999. The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol Psychiatry 46:1243-1252.
10. Goldin LR, Gershon ES, Lake CR, Murphy DL, McGinniss M, Sparkes RS. 1982. Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity. Am J Hum Genet 34:250-262.
11. Kane J, Honigfeld G, Singer J, Meltzer H. 1988. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796.
12. Klimek V, Rajkowska G, Luker SN, Dilley G, Meltzer HY, Overholser JC, Stockmeier CA, Ordway GA. 1999. Brain noradrenergic receptors in major depression and schizophrenia. Neuropsychopharmacology 21:69-81.
13. Lewontin RC. 1995. The detection of linkage disequilibrium in molecular sequence data. Genetics 140:377-388.
14. Litman RE, Hong WW, Weissman EM, Su TP, Potter WZ, Pickar D. 1993. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study. J Clin Psychopharmacol 13:264-267.
15. Long JC, Williams RC, Urbanek M. 1995. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 56:799-810.
16. Markianos ES, Nystrom I, Reichel H, Matussek N. 1976. Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol. Psychopharmacology 50:259-267.
17. Meszaros K, Lenzinger E, Fureder T, Hornik K, Willinger U, Stompe T, Heiden AM, Resinger E, Fathi N, Gerhard E, Fuchs K, Miller-Reiter E, Pfersmann V, Sieghart W, Aschauer HN, Kasper S. 1996. Schizophrenia and the dopamine-beta-hydroxylase gene: results of a linkage and association study. Psychiatr Genet 6:17-22.
18. Nahmias J, Burley MW, Povey S, Porter C, Craig I, Wolfe J. 1992. A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase locus. Hum Mol Genet 1:286.
19. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859; discussion 863-864.
20. O'Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE, Madrazo I, Langlais PJ, Robertson D, Biaggioni I. 1994. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clin Sci 86:149-158.
21. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G. 1986. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals-a genetic study. J Psychiatr Res 20:19-29.
22. Pritchard JK, Rosenberg NA. 1999. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65:220-228.
23. Sham PC, Curtis D. 1995. Monte Carlo tests for association between diseases and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
24. Stanley WC, Li B, Bonhaus DW, Johnson LG, Lee K, Porter S, Walker K, Martinez G, Eglen RM, Whiting RL, Hegde SS. 1997. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Brit J Pharmacol 121:1803-1809.
25. Sternberg DE, VanKammen DP, Lerner P, Bunney WE. 1982. Schizophrenia: dopamine beta-hydroxylase activity and treatment response. Science 216:1423-1425.
26. Sternberg DE, Van Kammen DP, Lerner P, Ballenger JC, Marder SR, Post RM, Bunney WE Jr. 1983. CSF dopamine beta-hydroxylase in schizophrenia. Arch Gen Psychiatry 40:743-747.
27. Van Kammen DP, Gelernter J. 1987. Biochemical instability in schizophrenia I: the norepinephrine system. In: Meltzer HY, editor. Psychopharmacology, the third generation of progress. New York: Raven Press.
28. Van Kammen DP, Mann LS, Sternberg DE, Scheinin M, Ninan PT, Marder SR, Van Kammen WB, Rieder RO, Linnoila M. 1983. Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy. Science 220:974-977.
29. Williams HJ, Bray N, Murphy KC, Cardno AG, Jones LA, Owen MJ. 1999. No evidence for allelic association between schizophrenia and a functional variant of the human dopamine beta-hydroxylase gene (DBH). Am J Med Genet 88:557-559.
30. Wilson AF, Elston RC, Siervogel RM, Tran LD. 1988. Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. Am J Hum Genet 42:160-166.
31. Woerner MG, Mannuzza S, Kane J. 1988. Anchoring the BPRS: an aid to improved reliability. Psychopharmacology Bulletin 24:112-117.